Connect With Us & Intercept the Diagnostic Odyssey

---

United for Early Detection and Cures.

We invite health systems, patient advocacy groups, and life sciences innovators to connect with our mission. As a 501(c)(3) non-profit consortium, we are dedicated to accelerating research and clinical interception for the public good, bridging the gap between local care and global cures.

Whether you are a hospital looking to catch "Metabolic Masqueraders" before crisis strikes , or a biotech company seeking trial-ready evidence for "Small N" populations, we are here to help scale your impact with our Regal Intel expertise.

How We Can Collaborate:

Request a Consultation: For Biotech, Pharma, and Research Sponsors: Schedule a complimentary 30-minute strategic assessment. We will discuss your specific needs regarding rescuing stranded therapeutics , Synthetic Control Arms, and how our global network, including Regal Technology Partners, can de-risk your regulatory submissions using biologically constrained, inspection-ready evidence . Book a Meeting below.

Join the Consortium: For Hospitals, Health Systems, and Academic Centers: Learn how to deploy a Sovereign Intelligence Node at your institution. Discover how you can participate in cutting-edge rare and complex disease research and access advanced diagnostic tools capable of calculating continuous biological velocity —all while keeping your patient data 100% secure and local via our "Code-to-Data" architecture. Inquire About Membership below.

Partner as a Fiduciary: For Patient Advocacy Groups and Academic Researchers: We believe cost should never be a barrier to saving lives. Learn how our consortium can help you structure prospective registries, secure non-dilutive federal grants , and apply "Synthetic Patient Twin" technology to your project. As an allied non-profit, our fiduciary model is designed specifically to be accessible and fiercely protective of your community's data sovereignty. Contact Our Team below.

Stay Connected: Join Our Network. Don't miss a breakthrough: Join our mailing list for exclusive updates on the rare and high-velocity disease landscape, insights into regulatory changes, and news about our latest consortium initiatives focused on early interception.

Contact Information

Email: service@regalintel.com

Direct Scheduling

Ready to talk now? Use the calendar link below to schedule a meeting directly with us.